Inaktiver Wert

Andere Sprachen Arca Biopharma Inc Nasdaq

Aktien

US00211Y4070

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	25.04.
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
North American Morning Briefing : Stock Futures -2-	19.04.
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	10.04.
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	05.04.
ARCA biopharma, Inc. Announces Management Changes	04.04.
ARCA biopharma, Inc. Announces Separation of Michael Bristow, Chief Executive Officer	04.04.
Sector Update: Health Care Stocks Softer Late Afternoon	03.04.
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	03.04.
Top Midday Gainers	03.04.
Sector Update: Health Care Stocks Rise Wednesday Afternoon	03.04.
Sector Update: Health Care	03.04.
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge	03.04.
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	03.04.
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	03.04.
Oruka Therapeutics announced that it expects to receive $275 million in funding	03.04.
ARCA biopharma Announces 2023 Financial Results	01.02.
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.02.
ARCA biopharma Announces Third Quarter 2023 Financial Results	18.10.23
ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arca Biopharma Inc Nasdaq

Aktien

US00211Y4070

Andere Sprachen

Filter